Grundlæggende statistik
| CIK | 1289496 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cord Blood America, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| September 23, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 18, 2020 CBA FLORIDA, INC. (Exact Name of Registrant as Specified in Its Charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
S-8 POS 1 s8posa111419001i08042020.htm As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. 333-127437 Registration Statement No. 333-129502 Registration Statement No. 333-141339 Registration Statement No. 333-148140 Registration Statement No. 333-152226 Registration Statement No. 333-155363 Registration Statement No. 333-158765 Registration Statement N |
|
| August 5, 2020 |
S-8 POS 1 s8posa111419001c08042020.htm As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. 333-127437 Registration Statement No. 333-129502 Registration Statement No. 333-141339 Registration Statement No. 333-148140 Registration Statement No. 333-152226 Registration Statement No. 333-155363 Registration Statement No. 333-158765 Registration Statement N |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| August 5, 2020 |
As filed with the Securities and Exchange Commission on August 4, 2020 Registration Statement No. |
|
| June 26, 2020 |
Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 25, 2020 CBA FLORIDA, INC. (Exact Name of Registrant as Specified in Its Charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| June 26, 2020 |
Articles of Dissolution of CBAI Florida, Inc. Exhibit 4.1 ARTICLES OF DISSOLUTION Pursuant to section 607.1403, Florida Statutes, this Florida profit corporation submits the following articles of dissolution: FIRST: The name of the corporation as currently filed with the Florida Department of State: CBA Florida, Inc. SECOND: The document number of the corporation (if known): P99000089885 THIRD: The date dissolution was authorized: May 28, 202 |
|
| June 16, 2020 |
Exhibit 99.1 CBA FLORIDA, INC. ANNOUNCES INITIAL CASH LIQUIDATING DISTRIBUTION $0.0062 per share to be paid on or about June 30, 2020 LAS VEGAS, NV / ACCESSWIRE / June 16, 2020 / CBA Florida, Inc. (www.cbafloridainc.com) (OTC PINK: CBAI) (“CBAI” or the “Company”) today announced that its Board of Directors (the “Board”) has approved an initial liquidating cash distribution of $0.0062 per share. Th |
|
| June 16, 2020 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2020 CBA FLORIDA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorp |
|
| June 2, 2020 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2020 CBA FLORIDA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorpo |
|
| May 14, 2020 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small Business Registrant as Specified i |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| April 20, 2020 |
CBAI / Cord Blood America, Inc. DEF 14A - - PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| April 17, 2020 |
CBAI / Cord Blood America, Inc. PRER14A - - PRER14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| April 15, 2020 |
EMAIL: [email protected] DIRECT DIAL: 212.451.2252 April 15, 2020 VIA EDGAR AND ELECTRONIC MAIL U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards and Celeste Murphy Re: CBA Florida, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 25, 2020 File No. 000-50746 Ladies |
|
| April 9, 2020 |
CORRESP 1 filename1.htm : EMAIL: [email protected] DIRECT DIAL: 212.451.2252 April 8, 2020 VIA EDGAR AND ELECTRONIC MAIL U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards and Celeste Murphy Re: CBA Florida, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 25, 2020 F |
|
| March 25, 2020 |
CBAI / Cord Blood America, Inc. 10-K - Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| March 25, 2020 |
EMAIL: [email protected] DIRECT DIAL: 212.451.2252 March 25, 2020 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: CBA Florida, Inc. Preliminary Proxy Statement on Schedule 14A (the “Proxy”) Ladies and Gentlemen: CBA Florida, Inc., a Florida corporation (the “Company”), has submitted in electronic format for filing with the U.S. Securities an |
|
| March 25, 2020 |
CBAI / Cord Blood America, Inc. PRE 14A - - PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| February 14, 2020 |
Plan of Dissolution of CBA Florida, Inc. Exhibit 2.1 PLAN OF DISSOLUTION OF CBA FLORIDA, INC. This Plan of Dissolution (this “Plan”), dated as of [DATE] (the “Plan Date”), is intended to accomplish the dissolution and winding up of CBA FLORIDA, INC., a Florida corporation (the “Corporation”), in accordance with the Florida Business Corporation Act (the “FBCA”). 1. Approval and Adoption of Plan. The directors of the Corporation (the “Dire |
|
| February 14, 2020 |
EX-99.1 3 ex991to8k1141900102132020.htm Exhibit 99.1 CBA FLORIDA, INC. ANNOUNCES INTENT TO CALL SHAREHOLDER MEETING, PROPOSES APPROVAL OF PLAN OF LIQUIDATION AND DISSOLUTION LAS VEGAS, NV / ACCESSWIRE / February 11, 2020 / CBA Florida, Inc. (www.cbafloridainc.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced that its Board of Directors (the “Board”) has approved a Plan of Liquidation |
|
| February 14, 2020 |
Financial Statements and Exhibits, Other Events 8-K 1 form8k1141900102132020.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 11, 2020 CBA FLORIDA, INC. (Exact Name of Registrant as Specified in Its Charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction o |
|
| November 15, 2019 |
CBAI / Cord Blood America, Inc. 10-Q/A - Quarterly Report - AMENDED QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small Business R |
|
| November 14, 2019 |
CBAI / Cord Blood America, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small Business Registrant as Specifi |
|
| August 14, 2019 |
CBAI / Cord Blood America, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small Business Registrant as Specified in |
|
| May 15, 2019 |
CBAI / Cord Blood America, Inc. 10-Q Quarterly Report QUARTERLY REPORT 10-Q 1 cbai10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Smal |
|
| April 1, 2019 |
CBAI / Cord Blood America, Inc. ANNUAL REPORT (Annual Report) 10-K 1 cbai10k.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) ☐ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 00 |
|
| November 14, 2018 |
CBAI / Cord Blood America, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small Business Registrant as Specifi |
|
| August 14, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2018 CBA FLORIDA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of Inco |
|
| August 14, 2018 |
CBA Florida, Inc. Provides 2018 Second Quarter Update EX-99.1 2 cbaiex991.htm PRESS RELEASE Exhibit 99.1 CBA Florida, Inc. Provides 2018 Second Quarter Update LAS VEGAS, NV / ACCESSWIRE / August 14, 2018 / CBA Florida, Inc. (www.cbafloridainc.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced an update for the second quarter ended June 30, 2018. Highlights Include: ● The Company completed its previously announced sale of assets to Califo |
|
| August 14, 2018 |
CBAI / Cord Blood America, Inc. QUARTERLY REPORT (Quarterly Report) 10-Q 1 cbai10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CBA FLORIDA, INC. (Exact Name of Small |
|
| May 31, 2018 |
ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF CBA FLORIDA, INC. |
|
| May 31, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 31, 2018 CBA Florida, Inc. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| May 29, 2018 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 29, 2018 CBA FLORIDA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| May 25, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 22, 2018 CBA Florida, Inc. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| May 25, 2018 |
EX-3.1 2 ex31to8k1141900305232018.htm Exhibit 3.1 |
|
| May 17, 2018 |
Articles of Amendment to Articles of Incorporation of Cord Blood America, Inc. Exhibit 3.1 |
|
| May 17, 2018 |
Cord Blood America, Inc. Announces Closing of Sale of Business Exhibit 99.1 Cord Blood America, Inc. Announces Closing of Sale of Business LAS VEGAS, NV / ACCESSWIRE / May 17, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced that it has closed its previously announced definitive asset purchase agreement (the “Purchase Agreement”) with California Cryobank Stem Cell Services LLC (“FamilyCord” |
|
| May 17, 2018 |
8-K 1 form8k1141900305172018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 16, 2018 CBA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporati |
|
| May 15, 2018 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders 8-K 1 form8k1141900305142018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 14, 2018 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction |
|
| May 15, 2018 |
Cord Blood America, Inc. Announces Shareholder Approval of Sale of Business Exhibit 99.1 Cord Blood America, Inc. Announces Shareholder Approval of Sale of Business LAS VEGAS, NV / ACCESSWIRE / May 15, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced today announced that at a Special Meeting of Shareholders held on May 14, 2018 (the “Special Meeting”), its shareholders authorized the previously announce |
|
| May 14, 2018 |
CBAI / Cord Blood America, Inc. QUARTERLY REPORT (Quarterly Report) 10-Q 1 cbai10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name |
|
| May 14, 2018 |
Cord Blood America, Inc. Reports 2018 First Quarter Results Cord Blood America, Inc. Reports 2018 First Quarter Results May 14, 2018 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced financial results for the first quarter ended March 31, 2018. Given the agreement entered into with California Cryobank Stem Cell Services LLC (dba “FamilyCord”) to sell substantially all of the Company’s assets, |
|
| May 14, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| April 26, 2018 |
Exhibit 3.1 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF CORD BLOOD AMERICA, INC. DESIGNATING SERIES A PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT Cord Blood America, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter called the “Corporation”), in accordance with the provisions of Section 607.0602 thereof |
|
| April 26, 2018 |
CBAI / Cord Blood America, Inc. 8-A12G 8-A12G 1 form8a12g1141900304252018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Cord Blood America, Inc. (Exact Name of Registrant as Specified in Its Charter) Florida 000-50746 90-0613888 (State or other jurisdiction (Commission (IRS Emp |
|
| April 26, 2018 |
Exhibit 4.1 TAX BENEFITS PRESERVATION PLAN dated as of April 25, 2018 between CORD BLOOD AMERICA, INC. and Issuer Direct Corporation as Rights Agent Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 6 Section 3. Issuance of Rights Certificates 6 Section 4. Form of Rights Certificates 8 Section 5. Countersignature and Registration 8 Section 6. Transfer, Split-Up, Combination a |
|
| April 26, 2018 |
Exhibit 4.1 TAX BENEFITS PRESERVATION PLAN dated as of April 25, 2018 between CORD BLOOD AMERICA, INC. and Issuer Direct Corporation as Rights Agent Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 6 Section 3. Issuance of Rights Certificates 6 Section 4. Form of Rights Certificates 8 Section 5. Countersignature and Registration 8 Section 6. Transfer, Split-Up, Combination a |
|
| April 26, 2018 |
Cord Blood America, Inc. Adopts Tax Benefits Preservation Plan Exhibit 99.1 Cord Blood America, Inc. Adopts Tax Benefits Preservation Plan LAS VEGAS, NV / ACCESSWIRE / April 25, 2018 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC PINK: CBAI) ("CBAI" or the "Company") today announced that its Board of Directors has adopted a tax benefits preservation plan (the "Plan") designed to preserve CBAI's ability to utilize its net operating loss carryforwa |
|
| April 26, 2018 |
Exhibit 3.1 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF CORD BLOOD AMERICA, INC. DESIGNATING SERIES A PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT Cord Blood America, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter called the “Corporation”), in accordance with the provisions of Section 607.0602 thereof |
|
| April 26, 2018 |
8-K 1 form8k1141900304252018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2018 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdicti |
|
| April 16, 2018 |
CBAI / Cord Blood America, Inc. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 2, 2018 |
CBAI / Cord Blood America, Inc. ANNUAL REPORT (Annual Report) 10-K 1 cbai10k.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) ☐ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 00 |
|
| April 2, 2018 |
EXHIBIT 21 List of Subsidiaries 1. Cord Partners Inc., a Florida corporation 2. CorCell Companies Inc., a Nevada corporation 3. CorCell Limited, a Nevada corporation 4. CBA Properties, Inc., a Florida corporation 5. Career Channel Inc. (formerly D/B/A RainMakers International), a Florida corporation |
|
| April 2, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2018 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| April 2, 2018 |
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2017 Exhibit 99.1 Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2017 April 2, 2018 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for fiscal year 2017. Given the agreement entered into with California Cryobank Stem Cell Services LLC (dba “FamilyCord”) to sell substantially al |
|
| March 8, 2018 |
CBAI / Cord Blood America, Inc. PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| February 20, 2018 |
CBAI / Cord Blood America, Inc. / Red Oak Partners, LLC Activist Investment MacPac 8.0 Normal template CUSIP No. 21839P206 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cord Blood America, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) RED OAK PARTNERS, LLC Attn: David Sandberg 150 E Palmetto Park Road, Suite 80 |
|
| February 16, 2018 |
Joint Filing Agreement, dated February 16, 2018, by and among the Reporting Persons. Exhibit 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the time |
|
| February 16, 2018 |
CBAI / Cord Blood America, Inc. / Cryobank Holdings Llc - SC 13D Activist Investment SC 13D 1 s109098sch13d.htm SC 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Cord Blood America, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 21839P206 (CUSIP Number) Richard D. Jennings 11915 La Grange Avenue Los Angeles, California 90025 (310) 496-5693 (Name, Address and Telephone Number |
|
| February 15, 2018 |
CBAI / Cord Blood America, Inc. / CRYO CELL INTERNATIONAL INC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Amendment No. 3 Under the Securities Exchange Act of 1934 Cord Blood America, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 21839P206 (Cusip Number) Steven Lanter, Esq. Luse Gorman, PC 5335 Wisconsin Avenue, NW, Suite 780 Washington, D.C. 20015 (202) 274-20 |
|
| February 8, 2018 |
Exhibit 2.1 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (the ?Agreement?) is entered into as of February 6, 2018, by and between California Cryobank Stem Cell Services LLC, a California limited liability company (the ?Buyer?), and Cord Blood America, Inc., a Florida corporation (the ?Seller?). The Buyer and the Seller are collectively referred to herein as the ?Parties? and individually |
|
| February 8, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 form8k1141900302072018.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 6, 2018 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdic |
|
| February 8, 2018 |
Cord Blood America, Inc. Announces Agreement to Sell Substantially All of Its Assets to FamilyCord Exhibit 99.1 Cord Blood America, Inc. Announces Agreement to Sell Substantially All of Its Assets to FamilyCord February 7, 2018 - Cord Blood America, Inc. (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") announced today that it has entered into an agreement with California Cryobank Stem Cell Services LLC (dba ?FamilyCord?) for the sale of substantially all of its assets to FamilyCord for a pu |
|
| February 8, 2018 |
Exhibit 10.1 VOTING AGREEMENT THIS VOTING AGREEMENT (this ?Agreement?) is made as of February 6, 2018, among California Cryobank Stem Cell Services LLC, a California limited liability company (the ?Buyer?), and Cord Blood America, Inc., a Florida corporation (the ?Seller?), and each of the undersigned shareholders (each, a ?Shareholder?) of the Seller. Concurrently with the execution of this Agree |
|
| November 13, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R. |
|
| November 13, 2017 |
Cord Blood America Reports 2017 Third Quarter Results Blueprint Exhibit 99.1 Cord Blood America Reports 2017 Third Quarter Results November 13, 2017 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the third quarter ended September 30, 2017. Third Quarter Highlights Include: ? Total revenue for the third quarter was $0.75 million, a decrease of 3.5% from |
|
| November 13, 2017 |
CBAI / Cord Blood America, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as |
|
| August 11, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 cbai8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdicti |
|
| August 11, 2017 |
Cord Blood America Reports 2017 Second Quarter Results Blueprint Exhibit 99.1 Cord Blood America Reports 2017 Second Quarter Results August 11, 2017 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the second quarter ended June 30, 2017. Second Quarter Highlights Include: ? Total revenue for the second quarter was $0.75 million, a decrease of 5.9% from tot |
|
| August 11, 2017 |
CBAI / Cord Blood America, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Speci |
|
| July 20, 2017 |
8-K 1 cbai8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction |
|
| July 11, 2017 |
8-K 1 cbai8k.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction |
|
| July 11, 2017 |
Cord Blood America, Inc. Announces Resignation of Interim President Blueprint Exhibit 99.9 Cord Blood America, Inc. Announces Resignation of Interim President July 11, 2017 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced that Stephen Morgan will resign from his positions as Interim President, General Counsel, and Corporate Secretary effective July 19, 2017, in order to pursue other career |
|
| May 31, 2017 |
Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (As Permitted by Rul |
|
| May 30, 2017 |
Cord Blood America PRIMARY DOCUMENT Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? SCHEDULE 14A ??????? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant ? Filed by Party other than Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| May 15, 2017 |
Cord Blood America Reports 2017 First Quarter Results Blueprint Exhibit 99.1 Cord Blood America Reports 2017 First Quarter Results May 15, 2017 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the first quarter ended March 31, 2017. First Quarter Highlights Include: ? Total revenue for the first quarter was $0.75 million, a decrease of 24.4% from total re |
|
| May 15, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Em |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Spec |
|
| May 8, 2017 |
Cord Blood America PRELIMINARY PROXY STATEMENT Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? SCHEDULE 14A ??????? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant ? Filed by Party other than Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| March 28, 2017 |
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2016 Blueprint Exhibit 99.1 Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2016 March 28, 2017 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the fourth quarter and fiscal year 2016. Highlights Include: ? Total revenue for the fourth quarter 2016 was $0.73 million, a decre |
|
| March 28, 2017 |
Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| March 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| March 20, 2017 |
THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT Blueprint Exhibit 10.1 THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (?Amendment?) is effective as of March 31, 2017 (?Effective Date?), and is entered into by and between Stephen Morgan (the ?Employee?), and Cord Blood America, Inc., a Florida corporation (the ?Company?). The Employee and the Company may be referred to collectively herein |
|
| March 20, 2017 |
Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 20, 2017 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| November 14, 2016 |
Cord Blood America Reports 2016 Third Quarter Financial Results Blueprint Exhibit 99.1 Cord Blood America Reports 2016 Third Quarter Financial Results November 14, 2016 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the third quarter ended September 30, 2016. Third Quarter Highlights Include: ? Total revenue for the third quarter 2016 was $0.77 million, a decreas |
|
| November 14, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2016 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R. |
|
| November 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 cbai10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact N |
|
| August 12, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2016 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| August 12, 2016 |
Cord Blood America Reports 2016 Second Quarter Financial Results Blueprint Exhibit 99.1 Cord Blood America Reports 2016 Second Quarter Financial Results August 12, 2016 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the second quarter ended June 30, 2016. Second Quarter Highlights Include: ? Total revenue for the second quarter 2016 was $0.79 million, a decrease o |
|
| August 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Speci |
|
| May 16, 2016 |
Cord Blood America Reports 2016 First Quarter Financial Results cbaiex991.htm Exhibit 99.1 Cord Blood America Reports 2016 First Quarter Financial Results May 16, 2016 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the first quarter ended March 31, 2016. First Quarter Highlights Include: ? Total revenue for the first quarter 2016 was $0.99 million, a decrease of |
|
| May 16, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2016 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 cbai10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name |
|
| April 13, 2016 |
Amendment No. 2 to Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Amendment No. 2 Under the Securities Exchange Act of 1934 Cord Blood America, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 21839P206 (Cusip Number) Steven Lanter, Esq. Luse Gorman, PC 5335 Wisconsin Avenue, NW, Suite 780 Washington, |
|
| March 30, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2016 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) ( |
|
| March 30, 2016 |
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015 cbaiex991.htm Exhibit 99.1 Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015 March 30, 2016 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the fourth quarter and fiscal year 2015. Highlights Include: ? Total revenue for the fourth quarter 2015 was $1.13 million, a d |
|
| March 30, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| February 19, 2016 |
cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2016 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R |
|
| February 19, 2016 |
Cord Blood America, Inc. Announces Strategic Update cbaiex991.htm Exhibit 99.1 Cord Blood America, Inc. Announces Strategic Update February 19, 2016 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company") today announced that the Board has approved the engagement of Boxwood Partners, LLC to advise the Company in its review of strategic alternatives. Coincident with this engagement ? which follows a recent outsou |
|
| February 19, 2016 |
SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT cbaiex102.htm Exhibit 10.2 SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (?Amendment?), effective as of February 12, 2016 (?Effective Date?), is entered into by and between Stephen Morgan (the ?Employee?), and Cord Blood America, Inc., a Florida corporation (the ?Company?). The Employee and the Company may be referred to collectively her |
|
| February 19, 2016 |
cbaiex101.htm Exhibit 10.1 MUTUAL SEPARATION AGREEMENT THIS MUTUAL SEPARATION AGREEMENT (?Agreement?) is made and entered into by and between Joseph R. Vicente (hereinafter referred to as ?Employee?), and Cord Blood America, Inc., including all of its subsidiaries and affiliates (hereinafter collectively referred to as the ?Company?). The Company and Employee are sometimes referred to herein indiv |
|
| December 10, 2015 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commissi |
|
| December 10, 2015 |
CBAI Announces Review of Strategic Alternatives EX-99.1 2 cbaiex991.htm PRESS RELEASE Exhibit 99.1 CBAI Announces Review of Strategic Alternatives LAS VEGAS, NV / ACCESSWIRE / December 10, 2015 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company") today announced that its Board of Directors (the “Board”) has unanimously determined to undertake a review of strategic alternatives available to the Company, wh |
|
| November 16, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as |
|
| November 16, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R |
|
| November 16, 2015 |
cbaiex991.htm Exhibit 99.1 Cord Blood America Reports 2015 Third Quarter Financial Results Revenue increased 19%, EBITDA of $0.33 million November 16, 2015 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the third quarter ended September 30, 2015. Third Quarter Highlights Include: ? Revenue increased |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Speci |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business |
|
| August 13, 2015 |
cbaiex161.htm Exhibit 16.1 August 12, 2015 Securities and Exchange Commission 100 F Street NE Washington, DC 20549 RE: Cord Blood America, Inc. We have read the statements that we understand Cord Blood America, Inc. will include under Item 4.01 of the Form 8-K report it will file regarding the recent change of auditors. We agree with such statements made regarding our firm. Very truly yours, De Jo |
|
| August 13, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| August 10, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) ( |
|
| August 10, 2015 |
Exhibit 3(i) ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF CORD BLOOD AMERICA, INC. |
|
| July 9, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Co |
|
| June 11, 2015 |
Cord Blood America PROXY STATEMENT cbaidef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? SCHEDULE 14A ??????? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (As Permitt |
|
| May 29, 2015 |
SECOND AMENDED AND RESTATED CORD BLOOD AMERICA, INC. ARTICLE 1- SHAREHOLDERS cbaiex3.htm Exhibit 3 SECOND AMENDED AND RESTATED BY-LAWS OF CORD BLOOD AMERICA, INC. ARTICLE 1- SHAREHOLDERS 1.1 Place of Meetings. All meetings of shareholders shall be held at such place within or without the State of Florida as may be designated from time to time by the Board of Directors or a Chief Executive Officer (or, if there is no Chief Executive Officer, a President) or, if not so desig |
|
| May 29, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. E |
|
| May 22, 2015 |
Cord Blood America PROXY STATEMENT cbaipre14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? SCHEDULE 14A ??????? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: ? Preliminary Proxy Statement o Confidential, For Use of the Commission Only (As Permitt |
|
| May 18, 2015 |
CBAI / Cord Blood America, Inc. / Red Oak Partners, LLC Activist Investment MacPac 8.0 Normal template CUSIP No. 21839P206 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Cord Blood America, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) RED OAK PARTNERS, LLC Attn: David Sandberg 1969 SW 17th St. Boca Raton, FL 334 |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————— FORM 10-Q ———————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business |
|
| May 14, 2015 |
SC 13D/A 1 d926654dsc13da.htm SCHEDULE 13D AMEND NO 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Amendment No. 1 Under the Securities Exchange Act of 1934 Cord Blood America, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 21839P206 (Cusip Number) Steven Lanter, Esq. Luse Gorman, PC 5335 Wisconsin Avenue, NW, |
|
| May 13, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Em |
|
| May 8, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Em |
|
| May 8, 2015 |
ex991.htm Exhibit 99.1 Cord Blood America Reports 2015 First Quarter Financial Results and Results of Special Shareholder Meeting, Announces Annual General Meeting Revenue Increased 39%, EBITDA of $0.208 million Shareholders Approve Increase in Authorized Shares May 8, 2015 - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced f |
|
| April 22, 2015 |
Cord Blood America DEFINITIVE ADDITIONAL MATERIALS cbaidefa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ??????? SCHEDULE 14A ??????? Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant ? Filed by Party other than Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rul |
|
| April 22, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| April 16, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| April 14, 2015 |
PREFERRED STOCK PURCHASE AGREEMENT cbaiex101.htm Exhibit 10.1 PREFERRED STOCK PURCHASE AGREEMENT THIS PREFERRED STOCK PURCHASE AGREEMENT (this ?Agreement?) is effective as of April 9, 2015 (the ?Execution Date?), by and between CORD BLOOD AMERICA, INC., a Florida corporation (the ?Company?), and the purchaser identified on the signature page hereto (the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Ag |
|
| April 14, 2015 |
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT cbaiex105.htm Exhibit 10.5 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This Amendment to the Executive Employment Agreement of Stephen Morgan (the "Amendment") effective as of April 1, 2015, (the ?Agreement?) is entered into as of April 9, 2015 (the ?Effective Date?), by and between Stephen Morgan (the ?Employee?), on the one hand, and Cord Blood America, Inc., a Florida corporation having its pri |
|
| April 14, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (C |
|
| April 14, 2015 |
cbaiex103.htm Exhibit 10.3 ARTICLES OF AMENDMENT TO ARTICLES OF INCORPORATION OF CORD BLOOD AMERICA. INC. DESIGNATING SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 607.0602 OF THE FLORIDA BUSINESS CORPORATION ACT Cord Blood America, Inc., a corporation organized and existing under Florida Business Corporation Act (hereinafter called the ?Corporation?), in accordance with the provisions |
|
| April 14, 2015 |
EX-10.2 3 cbaiex102.htm STOCKHOLDER AGREEMENT Exhibit 10.2 STOCKHOLDER AGREEMENT STOCKHOLDER AGREEMENT, dated as of April , 2014 (this “Agreement”), by and between Red Oak Fund LP, The Red Oak Long Fund LP and Pinnacle Opportunities Fund, LP (collectively, the “Red Oak Funds”), and Cord Blood America, Inc., a Florida corporation (the “Company”). WHEREAS, as of the date hereof, the Red Oak Funds wi |
|
| April 14, 2015 |
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT cbaiex104.htm Exhibit 10.4 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This Amendment to the Executive Employment Agreement of Joseph Vicente (the "Amendment") previously entered into as of January 1, 2015, (the ?Agreement?) is entered into as of April 9, 2015 (the ?Effective Date?), by and between Joseph Vicente (the ?Employee?), on the one hand, and Cord Blood America, Inc., a Florida corporatio |
|
| April 10, 2015 |
cbai991.htm Exhbit 99.1 Cord Blood America Announces Equity Investment by Red Oak Partners, LLC for Purposes of Debt Retirement and to Focus on Forward Growth, Adjourns Special Meeting to May 7th LAS VEGAS, April 10, 2015/PRNewsire/ - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) (?CBAI? or the ?Company?) today announced it has executed a purchase agreement for th |
|
| April 10, 2015 |
Cord Blood America CURRENT REPORT (Current Report/Significant Event) cbai8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. |
|
| March 31, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| March 31, 2015 |
EXECUTIVE EMPLOYMENT AGREEMENT STEPHEN MORGAN EX-10.2 2 cbaiex102.htm EMPLOYMENT AGREEMENT Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT STEPHEN MORGAN This Agreement is made as of the Effective Date (defined below), by and between Cord Blood America, Inc, a Florida Corporation (the “Company” or “Employer”) and Stephen Morgan (“Employee”). WITNESSETH: In Consideration of the mutual covenants herein contained, the parties hereto agree as follows |
|
| March 20, 2015 |
CBAI / Cord Blood America, Inc. / CRYO CELL INTERNATIONAL INC - FORM 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Cord Blood America, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 21839P206 (Cusip Number) Steven Lanter, Esq. Luse Gorman, PC 5335 Wisconsin Avenue, NW, Suite 780 Washington, D.C. 20015 (202) 274-2000 (Name, Address and Tel |
|
| February 23, 2015 |
CBAI / Cord Blood America, Inc. DEFA14A - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e) |
|
| February 23, 2015 |
CBAI / Cord Blood America, Inc. DEF 14A - - DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 14A ——————— Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant þ Filed by Party other than Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ |
|
| January 23, 2015 |
Exhibit 99.1 Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested LAS VEGAS, January 23, 2015 /PRNewswire/ - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange Commission (www.sec.gov) |
|
| January 23, 2015 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2015 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commissio |
|
| January 23, 2015 |
CBAI / Cord Blood America, Inc. PRE 14A - - PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: þ Preliminary Proxy Statement o Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2)) o Defin |
|
| December 23, 2014 |
CONSENT TO ENTRY OF JUDGMENT BY CONFESSION Exhibit 10.5 CONSENT TO ENTRY OF JUDGMENT BY CONFESSION COUNTY ) ) ss. STATE OF ) Defendant, Cord Blood America, Inc., a Florida corporation (“Defendant”), hereby knowingly and voluntarily consents to the entry of either one of the Judgments by Confession attached hereto as Exhibit A and Exhibit B (collectively, the “Judgment by Confession”), to be entered in either federal or state court at the r |
|
| December 23, 2014 |
Exhibit 10.4 FIRST AMENDMENT TO GUARANTY This First Amendment (this “Amendment”) to that certain Guaranty dated June 27, 2012 (the “Guaranty”), is entered into on December 17, 2014 to be effective as of June 27, 2012, by CorCell Companies, Inc., a Nevada corporation (“CCCI”); CorCell, Ltd., a Nevada corporation (“CCL”); Cord Partners, Inc., a Florida corporation (“CPI”); CBA Properties, Inc., a Fl |
|
| December 23, 2014 |
SETTLEMENT AND EXCHANGE AGREEMENT EX-10.1 2 cbaiex101.htm SETTLEMENT AND EXCHANGE AGREEMENT Exhibit 10.1 SETTLEMENT AND EXCHANGE AGREEMENT This Settlement and Exchange Agreement (this “Agreement”), dated December 17, 2014 (the “Effective Date”), is entered into by and among St. George Investments LLC, a Utah limited liability company (formerly known as St George Investments LLC, an Illinois limited liability company) (“SGI”), Tona |
|
| December 23, 2014 |
EXECUTIVE EMPLOYMENT AGREEMENT JOSEPH R. VICENTE Exhibit 10.6 EXECUTIVE EMPLOYMENT AGREEMENT JOSEPH R. VICENTE This Agreement is made as of the Effective Date (defined below), by and between Cord Blood America, Inc, a Florida Corporation (the “Company” or “Employer”) and JOSEPH R. VICENTE (the “Employee”). WITNESSETH: In Consideration of the mutual covenants herein contained, the parties hereto agree as follows: 1. Employment. The Board of Direc |
|
| December 23, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2014 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| December 23, 2014 |
FIRST AMENDMENT TO SECURITY AGREEMENT Exhibit 10.3 FIRST AMENDMENT TO SECURITY AGREEMENT This First Amendment (this “Amendment”) to that certain Security Agreement dated June 27, 2012 (the “Agreement”), is entered into on December 17, 2014 to be effective as of June 27, 2012, by and among Cord Blood America, Inc., a Florida corporation (“CBAI”); CorCell Companies, Inc., a Nevada corporation (“CCCI”); CorCell, Ltd., a Nevada corporatio |
|
| December 23, 2014 |
SECURED CONVERTIBLE PROMISSORY NOTE Exchange Date: December 17, 2014 U.S. $2,500,000.00 Exhibit 10.2 THIS NOTE IS ISSUED IN EXCHANGE FOR (WITHOUT ANY ADDITIONAL CASH OR PROPERTY CONSIDERATION) THE SECURED CONVERTIBLE PROMISSORY NOTE IN THE ORIGINAL PRINCIPAL AMOUNT OF $1,252,000.00 ORIGINALLY ISSUED BY BORROWER (AS DEFINED BELOW) AS OF JUNE 27, 2012. FOR PURPOSES OF RULE 144, THE PARTIES INTEND THAT THIS NOTE BE DEEMED TO HAVE BEEN ISSUED ON JUNE 27, 2012. NEITHER THESE SECURITIES NO |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as |
|
| November 14, 2014 |
Exhibit 99.1 Cord Blood America Announces 2014 Third Quarter Financial Results Revcenue Increased 25%, Net Income Increases by $1.13 Million to $.54 Million From Continuing Operations Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended September 30, 2014. Third Quarter 2014 Highlights: ● O |
|
| November 14, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2014 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| October 3, 2014 |
Cord Blood America, Inc. Announces Divestiture of Biocordcell Argentina, S.A. Exhibit 99.2 Cord Blood America, Inc. Announces Divestiture of Biocordcell Argentina, S.A. LAS VEGAS, October 3, 2014 /PRNewswire/ - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced that it has sold its 50.004% ownership stake in Argentina based Biocordcell Argentina, S.A. (Bio) to Diego Rissola, current President and shareho |
|
| October 3, 2014 |
Exhibit 99.1 STOCK PURCHASE AGREEMENT The undersigned, CORD BLOOD AMERICA, INC. hereby submits to MR. DIEGO RISSOLA this IRREVOCABLE OFFER (the “Offer”) to enter into a STOCK PURCHASE AGREEMENT (hereinafter the “Agreement”). This Offer shall be valid until October 12, 2014 at 8 p.m. Argentina Time. It shall be deemed to be accepted if on or before such date, MR. DIEGO RISSOLA deposits in the bank |
|
| October 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2014 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Speci |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2014 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| August 14, 2014 |
Exhibit 99.1 Cord Blood America Announces 2014 Second Quarter Financial Results US Operations Drive Recurring Revenue Growth at Over 12% LAS VEGAS, August 14, 2014 /PRNewswire/ - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended June 30, 2014. Second Quarter 2014 Highlights: ● Total reve |
|
| May 15, 2014 |
Exhibit 99.1 Cord Blood America Announces 2014 First Quarter Financial Results Company Generated Record First Quarter Cash From Operations of $222,434 [15-May-2014] LAS VEGAS, May 15, 2014 /PRNewswire/ - Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2014. First Quarter 2014 |
|
| May 15, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2014 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————— FORM 10-Q ———————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business |
|
| March 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K cbai10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-50746 cord blood |
|
| March 31, 2014 |
Exhibit 10.24 FIRST AMENDMENT TO LEASE This First amendment to lease ("First Amendment") is made and entered into this day of January, 2014 and effective as of the 30th day of December, 2013, by and between SPENCER AIRPORT CENTER, LLC, a Delaware limited liability company ("Lessor") and CORD BLOOD AMERICA, Inc. ("Lessee"). WITNESSETH: WHEREAS, Lessor and Lessee entered into a written Standard Indu |
|
| January 14, 2014 |
CBAI / Cord Blood America, Inc. / St George Investments LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* Cord Blood America, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) Calendar Year 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| January 10, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commis |
|
| January 10, 2014 |
January 10, 2014 Mr. Steve Lo Staff Accountant Division of Corporate Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 8-K Filed January 3, 2014 File No. 000-50746 Dear Mr. Lo: We reviewed your January 6, 2014 letter (“Letter”) containing comments to Cord Blood America, Inc.’s (the “Company”) Current Report on Form 8-K filed wit |
|
| January 10, 2014 |
Exhibit 16.1 |
|
| January 3, 2014 |
Exhibit 16.1 |
|
| January 3, 2014 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employe |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as |
|
| October 22, 2013 |
Regulation FD Disclosure - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| October 1, 2013 |
EXHIBIT 99.2 Nate D. Ashcraft (9497) Email: [email protected] Jonathan K. Hansen (12349) Email: [email protected] HANSEN BLACK ANDERSON ASHCRAFT 2940 West Maple Loop Drive, Suite 103 Lehi, Utah 84043 Telephone: (80l) 922-5004 Facsimile: (80l) 922-5019 Attorneys for Defendants IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION CORD BLOOD AMERICA, INC.; a Florida corporatio |
|
| October 1, 2013 |
IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION EXHIBIT 99.1 Nate D. Ashcraft (9497) Email: [email protected] Jonathan K. Hansen (12349) Email: [email protected] HANSEN BLACK ANDERSON ASHCRAFT 2940 West Maple Loop Drive, Suite 103 Lehi, Utah 84043 Telephone: (80l) 922-5004 Facsimile: (80l) 922-5019 Attorneys for Defendants IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION CORD BLOOD AMERICA, INC.; a Florida corporatio |
|
| October 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| September 3, 2013 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer |
|
| September 3, 2013 |
Exhibit 99.1 David L. Mortensen (#8242) Email: [email protected] Jill M. Pohlman (#7602) Email: [email protected] Jose A. Abarca (#12762) Email: [email protected] STOEL RIVES LLP 201 South Main Street, Suite 1100 Salt Lake City, Utah 84111-4904 Telephone: (801) 328-3131 Facsimile: (801) 578-6999 Attorneys for Cord Blood America, Inc. IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CEN |
|
| August 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Registrant as Speci |
|
| May 20, 2013 |
CORD BLOOD AMERICA, INC. ANNOUNCES NEW SERVICE OFFERING EXHIBIT 99.1 CORD BLOOD AMERICA, INC. ANNOUNCES NEW SERVICE OFFERING Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced the launch of a new service offering for the storage of mesenchymal cells through its wholly owned subsidiary CorCell Companies, Inc. (CorCell). For additional information on the new service offering please vi |
|
| May 20, 2013 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2013 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————— FORM 10-Q ———————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business |
|
| April 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| January 22, 2013 |
CBAI / Cord Blood America, Inc. / St George Investments LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* Cord Blood America, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) March 10, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————— FORM 10-Q ———————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Busin |
|
| October 4, 2012 |
Cord Blood America, Inc. Announces Sale of Stake in stellacure, GmbH to Medivision Exhibit 99.1 Cord Blood America, Inc. Announces Sale of Stake in stellacure, GmbH to Medivision LAS VEGAS, October 2, 2012 – Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) (“CBAI” or the “Company”) today announced that it has sold its 51% stake in its German subsidiary, stellacure GmbH (“stellacure”) to Medivision mbH, headquartered in Hamburg, Germany (“Medivision |
|
| October 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| October 4, 2012 |
Exhibit 10.1 Certified Translation -1- Cover page of Notary Dr. Arne Helms Deed roll no. 2924/2012 HL Agreement On Waiver of Claims, Purchase and Assignment of Claims Agreement and Share Purchase Agreement (File no.: 2005:00646/HL/IS) NOTARIAL DEED OF DR. ARNE HELMS NOTARY IN HAMBURG - CERTIFIED COPY - Certified Translation -2- 1. Deed roll no. 2924/2012 HL Negotiated in in the Free and Hanseatic |
|
| September 27, 2012 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| September 27, 2012 |
ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION CORD BLOOD AMERICA, INC. EXHIBIT 3.01 ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF CORD BLOOD AMERICA, INC. Pursuant to the provisions of Section 607.1006, Florida Statutes, Cord Blood America, Inc., a Florida corporation (the “Corporation”), adopts the following Articles of Amendment to its Amended and Restated Articles of Incorporation: FIRST: The Amended and Restated Articles of Incorp |
|
| August 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 14A ——————— Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant þ Filed by Party other than Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————— FORM 10-Q ———————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business R |
|
| August 14, 2012 |
EXECUTIVE EMPLOYMENT AGREEMENT STEPHEN MORGAN EXHIBIT 10.35 EXECUTIVE EMPLOYMENT AGREEMENT STEPHEN MORGAN This Agreement is made as of the Effective Date (defined below), by and between Cord Blood America, Inc, a Florida Corporation (the “Company” or “Employer”) and Stephen Morgan (“Employee”). WITNESSETH: In Consideration of the mutual covenants herein contained, the parties hereto agree as follows: 1. Employment. The Board of Directors of t |
|
| July 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— SCHEDULE 14A ——————— Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant þ Filed by Party other than Registrant o Check the appropriate box: þ Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o |
|
| July 6, 2012 |
INTERCREDITOR SUBORDINATION AGREEMENT EX-10.14 8 cbaiex1014.htm INTERCREDITOR SUBORDINATION AGREEMENT EXHIBIT 10.14 INTERCREDITOR SUBORDINATION AGREEMENT THIS INTERCREDITOR SUBORDINATION AGREEMENT (“Agreement”), dated this 27th day of June, 2012, is made by and between HAVI ENTERPRISES, LLC (“HAVI”), TONAQUINT, INC. (“Tonaquint”), and CORD BLOOD AMERICA, INC. (“CBAI”). RECITALS HAVI has previously loaned funds to CBAI (such loan is re |
|
| July 6, 2012 |
EXHIBIT 10.8 Cord Blood America, Inc. Secured Convertible Promissory Note Issuance Date: June 27, 2012 U.S. $1,252,000.00 This Secured Convertible Promissory Note (“Note”) is issued pursuant to that certain Securities Purchase Agreement dated June 27, 2012, as the same may be amended from time to time (the “Agreement”), by and between TONAQUINT, INC., a Utah corporation, or its registered assigns |
|
| July 6, 2012 |
CONSENT TO ENTRY OF JUDGMENT BY CONFESSION EXHIBIT 10.12 CONSENT TO ENTRY OF JUDGMENT BY CONFESSION COUNTY ) ) ss. STATE OF ) Defendant, Cord Blood America, Inc., a Florida corporation (“Defendant”), hereby knowingly and voluntarily waives service of process and consents to the entry of a Judgment by Confession in substantially the form attached hereto as Exhibit A, to be entered at the request of counsel for Tonaquint, Inc., a Utah corpor |
|
| July 6, 2012 |
Entry into a Material Definitive Agreement - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| July 6, 2012 |
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement, dated as of June 27, 2012 (this “Agreement”), is entered into by and between Cord Blood America, Inc., a Florida corporation (the “Company”), and Tonaquint, Inc., a Utah corporation, its successors and/or assigns (“Buyer”). RECITALS: A. The Company and the Buyer are executing and delivering this Agreement in reliance up |
|
| July 6, 2012 |
EXHIBIT 10.9 SECURITY AGREEMENT This Security Agreement (this “Security Agreement”), dated as of June 27, 2012, is executed by Cord Blood America, Inc., a Florida corporation (“CBAI”); CorCell Companies, Inc., a Nevada corporation (“CCCI”); CorCell, Ltd., a Nevada corporation (“CCL”); Cord Partners, Inc., a Florida corporation (“CPI”); CBA Professional Services, Inc., d/b/a/ BodyCells, Inc., a Flo |
|
| July 6, 2012 |
[Remainder of page intentionally left blank; signature page to follow] EXHIBIT 10.13 GUARANTY THIS GUARANTY, made effective as of June 27, 2012, is given by CorCell Companies, Inc., a Nevada corporation (“CCCI”); CorCell, Ltd., a Nevada corporation (“CCL”); Cord Partners, Inc., a Florida corporation (“CPI”); CBA Professional Services, Inc., d/b/a/ BodyCells, Inc., a Florida corporation (“CBAPSI”); CBA Properties, Inc., a Florida corporation (“CBAPI”); and Career Chan |
|
| July 6, 2012 |
IRREVOCABLE INSTRUCTIONS TO TRANSFER AGENT EXHIBIT 10.11 IRREVOCABLE INSTRUCTIONS TO TRANSFER AGENT Date: June 28, 2012 To the transfer agent of CORD BLOOD AMERICA, INC. Re: Instruction to Reserve and Transfer Shares Ladies and Gentlemen: Reference is made to that certain Secured Convertible Promissory Note dated as of June 27, 2012 (the “Note”), made by Cord Blood America, Inc., a Florida corporation (the “Company”), pursuant to which the |
|
| July 6, 2012 |
EX-10.15 9 cbaiex1015.htm FINAL AND FULL PAYMENT AGREEMENT WITH JMJ FINANCIAL EXHIBIT 10.15 Full and Final Payment Agreement for Notes: B-12172009b C-12172009b B-11192010a C-11192010a B-03012010a C-03012010a B-03012010b C-03012010b Cord Blood America, Inc. This Full and Final Payment Agreement ("Agreement") dated June 15, 2012 is by and between Cord Blood America, Inc. (the "Company") and JMJ Fina |
|
| June 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| June 25, 2012 |
BioCells (Argentina) and Cord Blood America, EX-99.1 3 cbaiex991.htm PRESS RELEASE Exhibit 99.1 BioCells (Argentina) and Cord Blood America, Inc. Reach Agreement on Payments LAS VEGAS, NV. June 25, 2012 - Cord Blood America, Inc. (OTC BB: CBAI) is pleased to announce it has finalized an Agreement with the individuals from whom CBAI acquired its majority interest in BioCordcell (BioCells) Argentina, S.A. regarding the 2011 earn-out, previousl |
|
| June 25, 2012 |
EX-10.1 2 cbaiex101.htm AGREEMENT Exhibit 10.1 AGREEMENT This Agreement (“Agreement”) is entered into by and between Cord Blood America, Inc., a corporation duly organized under the laws of the state of Florida, United States of America, with its principal place of business in Las Vegas, Nevada 89119 (the “Company”) on the one hand, and SEBASTIÁN NICOLÁS NEUSPILLER, domiciled in Buenos Aires, Arge |
|
| May 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q/A Amendment No. 1 ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Nam |
|
| May 25, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| May 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to ——————— CORD BLOOD AMERICA, INC. (Exact Name of Small Bus |
|
| May 18, 2012 |
May 18, 2012 Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-K for Fiscal Year Ended December 31, 2011 Filed April 16, 2012 File No. 000-50746 Dear Ms. Jenkins: We reviewed your May 4, 2012 letter (“Letter”) containing comments to Cord Blood Ameri |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2012 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 90-0613888 (State or Other Jurisdiction (Commission (I.R.S. Employer of |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form |
|
| April 17, 2012 |
April 17, 2012 Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-Q for Fiscal Quarter Ended September 30, 2011 Filed November 14, 2011 File No. 000-50746 Dear Ms. Jenkins: We reviewed your April 11, 2012 letter (“Letter”) containing comments to Cord |
|
| April 16, 2012 |
CBAI / Cord Blood America, Inc. / St George Investments LLC - ST. GEORGE CBAI 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 Cord Blood America, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) March 10, 2011 (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| April 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (MARK ONE) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. |
|
| March 30, 2012 |
March 12, 2012 Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-Q for Fiscal Quarter Ended September 30, 2011 Filed November 14, 2011 File No. 000-50746 Dear Ms. Jenkins: We reviewed your February 14, 2012 letter (“Letter”) containing comments to C |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): þ Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Fo |
|
| March 12, 2012 |
March 12, 2012 Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-Q for Fiscal Quarter Ended September 30, 2011 Filed November 14, 2011 File No. 000-50746 Dear Ms. Jenkins: We reviewed your February 14, 2012 letter (“Letter”) containing comments to C |
|
| February 16, 2012 |
February 16, 2012 VIA EDGAR Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 RE: Cord Blood America, Inc. Form 10-Q for Fiscal Quarter Ended September 30, 2011 Filed November 14, 2011 File No. 000-50746 Dear Ms. Jenkins: We reviewed your February 14, 2012 letter (“Letter”) containing |
|
| February 14, 2012 |
CBAI / Cord Blood America, Inc. / Ironridge Global IV, Ltd. - FORM SC 13G/A Passive Investment United states Securities and exchange commission WashinGton, d.c. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) CORD BLOOD AMERICA, INC. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) February 14, 2012 (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pur |
|
| February 14, 2012 |
CORD BLOOD AMERICA, INC. 1857 Helm Drive Las Vegas, NV 89119 Via Edgar February 14, 2012 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington D.C. 20002 Re: Cord Blood America, Inc.; Request to Withdraw Registration Statement on Forms S-1 and S-1/A; SEC File Number: 333-174642 Ladies and Gentlemen: Pursuant to Rule 477(a) promulgated under t |
|
| January 3, 2012 |
As filed with the Securities and Exchange Commission on December 30, 2011 Registration No. |
|
| January 3, 2012 |
Convertible Promissory Note Executed March 26, 2010 between CBAI and JMJ Financial (46) Exhibit 10.113 SECURED & COLLATERALIZED PROMISSORY NOTE $750,000 PLUS INTEREST DUE & PAYABLE DOCUMENT C-03012010a THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT OR APPLICABLE EXEMPTION OR SAFE HARBOR PROVISION. FOR VALUE RECEIVED, on the Effect |
|
| January 3, 2012 |
Convertible Promissory Note Executed March 24, 2010 between CBAI and JMJ Financial (45) Exhibit 10.112 AMENDMENT CONVERTIBLE PROMISSORY NOTE DOCUMENT B-12172009b On or about February 26, 2010, the parties agreed that the following Convertible Promissory Note by and between Cord Blood America, Inc. and JMJ Financial is hereby amended as follows: · Document B-12172009b. Paragraph #3 of the December 18, 2009 letter agreement "Regarding Prepayment Terms Only on Document B-12172009b" is h |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Busines |
|
| October 28, 2011 |
EXHIBIT 10.96 SECURITIES PURCHASE AGREEMENT THIS AGREEMENT dated as of the 27 day of June 2008 (the “Agreement”) between TANGIERS INVESTORS, LP, a limited partnership (the “Investor”), and CORD BLOOD AMERICA, INC., a corporation organized and existing under the laws of the State of Florida (the “Company”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained her |
|
| October 28, 2011 |
As filed with the Securities and Exchange Commission on October 28, 2011 As filed with the Securities and Exchange Commission on October 28, 2011 Registration No. |
|
| October 7, 2011 |
October 7, 2011 VIA EDGAR Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 31, 2011 Amendment No. 1 to Form 10Q for Fiscal Quarter Ended June 30, 2011 Filed September 6, 2011 File No. 000-50746 |
|
| September 26, 2011 |
September 26, 2011 VIA EDGAR Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 31, 2011 Amendment No. 1 to Form 10Q for Fiscal Quarter Ended June 30, 2011 Filed September 6, 2011 File No. 000-507 |
|
| September 26, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q/A (Amendment No. 2) ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name o |
|
| September 22, 2011 |
EXHIBIT 10.96 SECURITIES PURCHASE AGREEMENT THIS AGREEMENT dated as of the 27th day of June 2008 (the "Agreement'") between TANQERS INVESTORS, LP, a limited partnership (the "Investor"'), and CORD BLOOD AMERICA INC., a corporation organized and existing under the laws of the State of Florida (the "Company"'). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained |
|
| September 22, 2011 |
As filed with the Securities and Exchange Commission on September 21, 2011 As filed with the Securities and Exchange Commission on September 21, 2011 Registration No. |
|
| September 12, 2011 |
EXECUTIVE EMPLOYMENT AGREEMENT JOSEPH R. VICENTE Exhibit 99.(1) EXECUTIVE EMPLOYMENT AGREEMENT JOSEPH R. VICENTE This Agreement is made as of the Effective Date (defined below), by and between Cord Blood America, Inc, a Florida Corporation (the “Company” or “Employer”) and JOSEPH R. VICENTE (the “Employee”). WITNESSETH: In Consideration of the mutual covenants herein contained, the parties hereto agree as follows: 1. Employment. The Board of Dir |
|
| September 12, 2011 |
EXECUTIVE EMPLOYMENT AGREEMENT MATTHEW L. SCHISSLER Exhibit 99.(2) EXECUTIVE EMPLOYMENT AGREEMENT MATTHEW L. SCHISSLER This Agreement is made as of the Effective Date (defined below), by and between Cord Blood America, Inc, a Florida Corporation (the “Company” or “Employer”) and MATTHEW L. SCHISSLER (the “Employee”). WITNESSETH: In Consideration of the mutual covenants herein contained, the parties hereto agree as follows: 1. Employment. The Board |
|
| September 12, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2011 CORD BLOOD AMERICA, INC. (Exact name of registrant as specified in its charter) Florida 000-50746 65-1078768 (State or Other Jurisdiction (Commission (I.R.S. Employ |
|
| September 6, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q /A ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business |
|
| September 6, 2011 |
September 2, 2011 VIA EDGAR Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 31, 2011 Form 10-Q for Fiscal Quarter Ended March 31, 2011 Filed May 23, 2011 File No. 000-50746 Dear Ms. Jenkins: We |
|
| September 6, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q/A ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to ——————— CORD BLOOD AMERICA, INC. (Exact Name of Small B |
|
| August 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 CORD BLOOD AMERICA, INC. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 21839P206 (CUSIP Number) August 17, 2011 (Date of Event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| August 19, 2011 |
August 19, 2011 VIA EDGAR Ms. Tia Jenkins Senior Assistant Chief Accountant UNITED STATES SECURITY AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street NE Washington, DC 20549 Re: Cord Blood America, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 31, 2011 Form 10-Q for Fiscal Quarter Ended March 31, 2011 Filed May 23, 2011 File No. 000-50746 Dear Ms. Jenkins: We r |
|
| August 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q ——————— þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from to CORD BLOOD AMERICA, INC. (Exact Name of Small Business Reg |
|
| July 18, 2011 |
As filed with the Securities and Exchange Commission on July 18 , 2011 As filed with the Securities and Exchange Commission on July 18 , 2011 Registration No. |
|
| July 1, 2011 |
As filed with the Securities and Exchange Commission on July 1, 2011 As filed with the Securities and Exchange Commission on July 1, 2011 Registration No. |
|
| June 3, 2011 |
CORD BLOOD AMERICA, INC. 2011 FLEXIBLE STOCK PLAN EXHIBIT 4.1 CORD BLOOD AMERICA, INC. 2011 FLEXIBLE STOCK PLAN ARTICLE I NAME AND PURPOSE 1.1 Name. The name of the Plan is the "Cord Blood America, Inc. 2011 Flexible Stock Plan." 3.2 Purpose. The Company has established the Plan to attract, retain, motivate and reward Employees and other individuals, to encourage ownership of the Company's Common Stock by Employees and other individuals, and to p |
|
| June 3, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM S-8 ——————— REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cord Blood America, Inc. (Exact name of registrant as specified in its charter) Florida 65-1078768 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1857 Helm Drive Las Vegas, NV 89119 (Address of |
|
| June 1, 2011 |
As filed with the Securities and Exchange Commission on June 1, 2011 As filed with the Securities and Exchange Commission on June 1, 2011 Registration No. |
